|
|
||||||||
the TOAST Investigators
From the Department of Neurology (Drs. Madden and Karanjia), Marshfield Clinic, Marshfield, WI; and the Departments of Neurology (Dr. Adams) and Preventive Medicine (Dr. Clarke), University of Iowa College of Medicine, Iowa City, IA.
Rapid identification of stroke subtype is valuable for both practicing clinicians and the optimal design of clinical stroke trials. Mechanisms of ischemic injury might differ among different stroke subtypes. Certain subtypes might be clinically identified as suboptimal for future therapeutic or prophylactic stroke trials. Some subtypes might be so clinically distinct that extensive laboratory investigation is unwarranted. Investigators in the ongoing Trial of ORG 10172 in Acute Stroke Treatment are using criteria to categorize stroke etiology among enrolled patients into one of five subtypes: large-artery atherothromboembolic, cardioembolic, small-vessel thrombotic, other etiology, or undetermined etiology. As part of the study, physicians initially predict the most likely subtype of stroke based on clinical features and baseline CT. Three months after stroke, investigators use the criteria, which also incorporate results of diagnostic testing, to reclassify stroke subtype. Initial clinical impression of subtype agreed with final determination in 62% of patients, and the rate was similar for all stroke subtypes. No stroke subtype was more accurately diagnosed than others by initial assessment. No subtype was more commonly identified by diagnostic studies. Fifteen percent of patients remained without a clear etiologic subtype diagnosis at 3 months. We conclude that clinical trials in stroke should not attempt to restrict entry into trials based on presumed stroke subtype. A careful evaluation for etiology is justified in all patients presenting with stroke, regardless of presumed subtype.
This article has been cited by other articles:
![]() |
D. Toni, M. L. Sacchetti, and M. Prencipe Early Clinical Diagnosis of Lacunar Strokes Stroke, October 1, 2008; 39(10): e152 - e152. [Full Text] [PDF] |
||||
![]() |
E.S. Rosenthal, L.H. Schwamm, L. Roccatagliata, S.B. Coutts, A.M. Demchuk, P.W. Schaefer, R.G. Gonzalez, M.D. Hill, E.F. Halpern, and M.H. Lev Role of Recanalization in Acute Stroke Outcome: Rationale for a CT Angiogram-Based "Benefit of Recanalization" Model AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): 1471 - 1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Meschia, L. D. Case, B. B. Worrall, R. D. Brown Jr, T. G. Brott, M. Frankel, S. Silliman, S. S. Rich, and for the Ischemic Stroke Genetics Study Group Family history of stroke and severity of neurologic deficit after stroke Neurology, October 24, 2006; 67(8): 1396 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mazighi, R. Tanasescu, X. Ducrocq, E. Vicaut, S. Bracard, E. Houdart, and F. Woimant Prospective study of symptomatic atherothrombotic intracranial stenoses: The GESICA Study Neurology, April 25, 2006; 66(8): 1187 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Meschia, B. M. Kissela, T. G. Brott, R. D. Brown Jr, B. B. Worrall, J. Beck, and A. N. Skarp The Siblings With Ischemic Stroke Study (SWISS): A Progress Report. Clin. Med. Res., March 1, 2006; 4(1): 12 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakamura, K. Yamada, O. Kizu, H. Ito, S. Yuen, T. Ito, K. Yoshikawa, K. Shiga, M. Nakagawa, and T. Nishimura Effect of Thin-Section Diffusion-Weighted MR Imaging on Stroke Diagnosis AJNR Am. J. Neuroradiol., March 1, 2005; 26(3): 560 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Y. Bang, S. Y. Joo, P. H. Lee, U. S. Joo, J. H. Lee, I. S. Joo, and K. Huh The Course of Patients With Lacunar Infarcts and a Parent Arterial Lesion: Similarities to Large Artery vs Small Artery Disease Arch Neurol, April 1, 2004; 61(4): 514 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C.C. Johnston and M. D. Hill The patient with transient cerebral ischemia: a golden opportunity for stroke prevention Can. Med. Assoc. J., March 30, 2004; 170(7): 1134 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Lovett, A. J. Coull, and P. M. Rothwell Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies Neurology, February 24, 2004; 62(4): 569 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-W. Kang, J. A. Chalela, M. A. Ezzeddine, and S. Warach Association of Ischemic Lesion Patterns on Early Diffusion-Weighted Imaging With TOAST Stroke Subtypes Arch Neurol, December 1, 2003; 60(12): 1730 - 1734. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Hsia, H. S. Sachdev, J. Tomlinson, S. A. Hamilton, and D. C. Tong Efficacy of IV tissue plasminogen activator in acute stroke: Does stroke subtype really matter? Neurology, July 8, 2003; 61(1): 71 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
S J Allder, A R Moody, A L Martel, P S Morgan, G S Delay, J R Gladman, and G G Lennox Differences in the diagnostic accuracy of acute stroke clinical subtypes defined by multimodal magnetic resonance imaging J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 886 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wassertheil-Smoller, S. Hendrix, M. Limacher, G. Heiss, C. Kooperberg, A. Baird, T. Kotchen, J. D. Curb, H. Black, J. E. Rossouw, et al. Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women: The Women's Health Initiative: A Randomized Trial JAMA, May 28, 2003; 289(20): 2673 - 2684. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ageno, S. Finazzi, L. Steidl, M. G. Biotti, V. Mera, G. Melzi d'Eril, and A. Venco Plasma Measurement of D-Dimer Levels for the Early Diagnosis of Ischemic Stroke Subtypes Arch Intern Med, December 9, 2002; 162(22): 2589 - 2593. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Blersch, B. M. Draganski, S. R. Holmer, H. J. Koch, F. Schlachetzki, U. Bogdahn, and T. Holscher Transcranial Duplex Sonography in the Detection of Patent Foramen Ovale Radiology, December 1, 2002; 225(3): 693 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Chang, M.-C. Tseng, H.-H. Weng, Y.-H. Lin, C.-W. Liou, and T.-Y. Tan Prediction of Length of Stay of First-Ever Ischemic Stroke Stroke, November 1, 2002; 33(11): 2670 - 2674. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ezzeddine, M. H. Lev, C. T. McDonald, G. Rordorf, J. Oliveira-Filho, F. G. Aksoy, J. Farkas, A. Z. Segal, L. H. Schwamm, R. G. Gonzalez, et al. CT Angiography With Whole Brain Perfused Blood Volume Imaging: Added Clinical Value in the Assessment of Acute Stroke Stroke, April 1, 2002; 33(4): 959 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.P. Mohr, J.L.P. Thompson, R.M. Lazar, B. Levin, R.L. Sacco, K.L. Furie, J.P. Kistler, G.W. Albers, L.C. Pettigrew, H.P. Adams Jr., et al. A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke N. Engl. J. Med., November 15, 2001; 345(20): 1444 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Goldstein, M. R. Jones, D. B. Matchar, L. J. Edwards, J. Hoff, V. Chilukuri, S. B. Armstrong, R. D. Horner, and J. Bamford Improving the Reliability of Stroke Subgroup Classification Using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Criteria Editorial Comment : Classifying the Mechanisms of Ischemic Stroke Stroke, May 1, 2001; 32(5): 1091 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Inzitari, M. Eliasziw, P. Gates, B. L. Sharpe, R. K.T. Chan, H. E. Meldrum, H. J.M. Barnett, and The North American Symptomatic Carotid Endarterect The Causes and Risk of Stroke in Patients with Asymptomatic Internal-Carotid-Artery Stenosis N. Engl. J. Med., June 8, 2000; 342(23): 1693 - 1701. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Furlan CVA: Reducing the Risk of a Confused Vascular Analysis : The Feinberg Lecture Stroke, June 1, 2000; 31(6): 1451 - 1456. [Full Text] [PDF] |
||||
![]() |
L. J. Lee, C. S. Kidwell, J. Alger, S. Starkman, and J. L. Saver Impact on Stroke Subtype Diagnosis of Early Diffusion-Weighted Magnetic Resonance Imaging and Magnetic Resonance Angiography Stroke, May 1, 2000; 31(5): 1081 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. M. Barnett, R. W. Gunton, M. Eliasziw, L. Fleming, B. Sharpe, P. Gates, and H. Meldrum Causes and Severity of Ischemic Stroke in Patients With Internal Carotid Artery Stenosis JAMA, March 15, 2000; 283(11): 1429 - 1436. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Toni, F. Iweins, R. von Kummer, O. Busse, J. Bogousslavsky, A. Falcou, E. Lesaffre, and G. L. Lenzi Identification of lacunar infarcts before thrombolysis in the ECASS I study Neurology, February 8, 2000; 54(3): 684 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Johnston, A. F. Connors Jr, D. P. Wagner, W. A. Knaus, X.-Q. Wang, and E. C. Haley Jr A Predictive Risk Model for Outcomes of Ischemic Stroke Stroke, February 1, 2000; 31(2): 448 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Adams Jr., B. H. Bendixen, E. Leira, K. C. Chang, P. H. Davis, R. F. Woolson, W. R. Clarke, and M. D. Hansen Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) Neurology, July 1, 1999; 53(1): 122 - 122. [Abstract] [Full Text] |
||||
![]() |
H. P. Adams Jr., P. H. Davis, E. C. Leira, K.-C. Chang, B. H. Bendixen, W. R. Clarke, R. F. Woolson, and M. D. Hansen Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) Neurology, July 1, 1999; 53(1): 126 - 126. [Abstract] [Full Text] |
||||
![]() |
The Publications Committee for the Trial of ORG 10 Low Molecular Weight Heparinoid, ORG 10172 (Danaparoid), and Outcome After Acute Ischemic Stroke: A Randomized Controlled Trial JAMA, April 22, 1998; 279(16): 1265 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D'Olhaberriague, I. Litvan, P. Mitsias, and H. H. Mansbach A Reappraisal of Reliability and Validity Studies in Stroke Stroke, December 1, 1996; 27(12): 2331 - 2336. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |